APPOINTMENTS NOVEMBER RAJ PHARMA 2006
This article was originally published in SRA
Christine Beerli will oversee operating duties at the Swiss healthcare products regulatory agency, Swissmedic, until a replacement is found for its former chief executive, Franz Schneller. Swissmedic announced Mr Schneller was leaving at the same time it announced a major restructuring of the agency. Ms Beerli is the chair of Swissmedic's Institute Council, the body which carried out a process and organisational analysis of the agency and identified deficiencies in terms of its management and processes.
You may also be interested in...
A lack of regulatory harmonization for dietary supplements in Asia is a big challenge facing companies operating in the region, according to experts from the Asia Regulatory Professionals Association. The ARPA is looking to start a conversation on the issue which the association hopes will lead to regulatory change.
The Chinese Society of Clinical Oncology (CSCO) annual meeting, against the background of the global pandemic, has one clear message that local researchers and players are pressing ahead to take a leadership role in cutting-edge cancer research globally.
Company is confident that data readout from pivotal trial could be ready before the end of 2020.